ArticleJournal of hematology & oncology2017

A hybrid of B and T lymphoblastic cell line could potentially substitute dendritic cells to efficiently expand out Her-2/neu-specific cytotoxic T lymphocytes from advanced breast cancer patients in vitro.

Sheng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.